These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31229565)

  • 1. Synthetic symbiosis combining plasmid displacement enables rapid construction of phenotype-stable strains.
    Zhang R; Yang Y; Wang J; Lin Y; Yan Y
    Metab Eng; 2019 Sep; 55():85-91. PubMed ID: 31229565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-free segregational plasmid stabilization in Escherichia coli owing to the knockout of triosephosphate isomerase (tpiA).
    Velur Selvamani RS; Telaar M; Friehs K; Flaschel E
    Microb Cell Fact; 2014 Apr; 13():58. PubMed ID: 24745552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Escherichia coli FAB system using synthetic plant genes for the production of long chain fatty acids.
    Kassab E; Fuchs M; Haack M; Mehlmer N; Brueck TB
    Microb Cell Fact; 2019 Oct; 18(1):163. PubMed ID: 31581944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient stress-free strategy to displace stable bacterial plasmids.
    Hale L; Lazos O; Haines A; Thomas C
    Biotechniques; 2010 Mar; 48(3):223-8. PubMed ID: 20359304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Genomic Integration Location on Heterologous Protein Expression and Metabolic Engineering in E. coli.
    Englaender JA; Jones JA; Cress BF; Kuhlman TE; Linhardt RJ; Koffas MAG
    ACS Synth Biol; 2017 Apr; 6(4):710-720. PubMed ID: 28055177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic stress constrains microbial L-cysteine production in Escherichia coli by accelerating transposition through mobile genetic elements.
    Heieck K; Arnold ND; Brück TB
    Microb Cell Fact; 2023 Jan; 22(1):10. PubMed ID: 36642733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic engineering applications of the Escherichia coli bacterial artificial chromosome.
    Sjöberg G; Guevara-Martínez M; van Maris AJA; Gustavsson M
    J Biotechnol; 2019 Nov; 305():43-50. PubMed ID: 31505217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Nonantibiotic,
    Terrinoni M; Nordqvist SL; Källgård S; Holmgren J; Lebens M
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29222103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique and its application to improve the Escherichia coli xylose utilization pathway.
    Zhu X; Zhao D; Qiu H; Fan F; Man S; Bi C; Zhang X
    Metab Eng; 2017 Sep; 43(Pt A):37-45. PubMed ID: 28800965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs.
    Na D; Yoo SM; Chung H; Park H; Park JH; Lee SY
    Nat Biotechnol; 2013 Feb; 31(2):170-4. PubMed ID: 23334451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using promoter libraries to reduce metabolic burden due to plasmid-encoded proteins in recombinant Escherichia coli.
    Pasini M; Fernández-Castané A; Jaramillo A; de Mas C; Caminal G; Ferrer P
    N Biotechnol; 2016 Jan; 33(1):78-90. PubMed ID: 26335036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli.
    Silva F; Queiroz JA; Domingues FC
    Biotechnol Adv; 2012; 30(3):691-708. PubMed ID: 22244816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration.
    Cranenburgh RM; Hanak JA; Williams SG; Sherratt DJ
    Nucleic Acids Res; 2001 Mar; 29(5):E26. PubMed ID: 11222777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nonauxotrophic L-homoserine hyperproducer in Escherichia coli by systems metabolic engineering.
    Cai M; Zhao Z; Li X; Xu Y; Xu M; Rao Z
    Metab Eng; 2022 Sep; 73():270-279. PubMed ID: 35961600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hok mRNA family.
    Steif A; Meyer IM
    RNA Biol; 2012 Dec; 9(12):1399-404. PubMed ID: 23324554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of broad-host-range reporter plasmid suitable for on-line analysis of bacterial host responses related to recombinant protein production.
    Gawin A; Peebo K; Hans S; Ertesvåg H; Irla M; Neubauer P; Brautaset T
    Microb Cell Fact; 2019 May; 18(1):80. PubMed ID: 31064376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic auxotrophs for stable and tunable maintenance of plasmid copy number.
    Kang CW; Lim HG; Yang J; Noh MH; Seo SW; Jung GY
    Metab Eng; 2018 Jul; 48():121-128. PubMed ID: 29864582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-β-lactamase gene blaIMP-6, leading to a carbapenem-susceptible phenotype in the blaIMP-6-positive Escherichia coli strain A56-1S.
    Segawa T; Sekizuka T; Suzuki S; Shibayama K; Matsui M; Kuroda M
    PLoS One; 2018; 13(12):e0208976. PubMed ID: 30533034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli.
    Ali SA; Chew YW; Omar TC; Azman N
    PLoS One; 2015; 10(12):e0144189. PubMed ID: 26642325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.